ÂÜÀòÂÒÂ×

Renske Van Leuken has extensive work experience in the field of medical technology, hematology, and oncology. Renske is currently serving as the Head of Medical Technology at the RIVM National Institute for Public Health and the Environment since May 2023. Prior to this role, they held the position of Disease Area Head Hematology at Bristol Myers Squibb from May 2020 to December 2022. Renske'sprevious experience includes working at Celgene as a Senior Manager Medical Affairs Hematology & Oncology from August 2018 to May 2020, and as a Medical Advisor in various oncology-related roles from July 2014 to October 2016. Before joining Celgene, they worked as a Medical Advisor Oncology at Bristol-Myers Squibb from September 2009 to July 2014. Renske also has experience as a Clinical Research Associate at Pfizer from January 2009 to September 2009. Renske started their career as a PhD student at UMC Utrecht from January 2005 to September 2008, and at the Dutch Cancer Institute (NKI) from January 2003 to February 2005.

Renske Van Leuken completed their bachelor's degree in Biomedical Sciences with a focus on Molecular Biology at Utrecht University from 1997 to 2002. The remaining education history is not provided.